According to Precedence Research, the global gRNA market size is expected to grow from USD 708.92 million in 2025 to nearly ...

The global cell and gene therapy market size is valued at USD 27.02 billion in 2025 and is predicted to hit around USD 232.22 ...

CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...

Scientists have used a new type of gene therapy to cure leukaemia patients. The treatment, which uses edited immune cells ...

CAR7, has shown remarkable success in reversing an aggressive form of leukemia. This world-first treatment uses gene ...

To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.

On the 4th, the European Union (EU), once dubbed the “GMO, genetically modified organisms, regulatory stronghold” and known ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Harvard scientists published thousands of studies in 2025, advancing knowledge and discovering solutions in a time when ...

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...